WEKO3
アイテム
{"_buckets": {"deposit": "623ba29b-36da-4e11-99aa-8938a39d85cb"}, "_deposit": {"created_by": 1, "id": "45814", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "45814"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00045814", "sets": ["1"]}, "author_link": ["455542", "455541", "455544", "455543", "455537", "455539", "455540", "455538"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2009-07", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "3", "bibliographicPageEnd": "836", "bibliographicPageStart": "831", "bibliographicVolumeNumber": "74", "bibliographic_titles": [{"bibliographic_title": "International Journal of Radiation Oncology Biology Physics"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "PURPOSE: To evaluate the efficacy and safety of hypofractionated proton beam therapy for patients with hepatocellular carcinoma (HCC). METHODS AND MATERIALS: Between September 2001 and August 2004, 51 patients with HCC greater than 2 cm away from the porta hepatis or gastrointestinal tract were treated with proton beam therapy to 66 Gy-equivalents (GyE) in 10 fractions. RESULTS: Overall survival rates were 49.2 and 38.7% at 3 and 5 years after treatment. Local control rates were 94.5 and 87.8% at 3 and 5 years after treatment. Posttreatment serum alpha-fetoprotein values were significantly reduced when compared with pretreatment values (p \u003c 0.0001). Patients experienced only minor acute reactions of Grade 1 or less, and 3 patients experienced late sequelae of Grade 2 or higher. However, there were no treatment-related deaths. CONCLUSIONS: Hypofractionated proton beam therapy is safe and well-tolerated by patients with HCC located greater than 2 cm away from the porta hepatis or gastrointestinal tract and may be effective alternative to other modalities.", "subitem_description_type": "Abstract"}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0360-3016", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Fukumitsu, Nobuyoshi"}], "nameIdentifiers": [{"nameIdentifier": "455537", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sugahara, Shinji"}], "nameIdentifiers": [{"nameIdentifier": "455538", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nakayama, Hidetsugu"}], "nameIdentifiers": [{"nameIdentifier": "455539", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsuboi, Koji"}], "nameIdentifiers": [{"nameIdentifier": "455540", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "et.al"}], "nameIdentifiers": [{"nameIdentifier": "455541", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "菅原 信二", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "455542", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "中山 秀次", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "455543", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "坪井 康次", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "455544", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "A Prospective Study of Hypofractionated Proton Beam Therapy for Patients with Hepatocellular Carcinoma", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "A Prospective Study of Hypofractionated Proton Beam Therapy for Patients with Hepatocellular Carcinoma"}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/45814", "pubdate": {"attribute_name": "公開日", "attribute_value": "2010-06-16"}, "publish_date": "2010-06-16", "publish_status": "0", "recid": "45814", "relation": {}, "relation_version_is_last": true, "title": ["A Prospective Study of Hypofractionated Proton Beam Therapy for Patients with Hepatocellular Carcinoma"], "weko_shared_id": -1}
A Prospective Study of Hypofractionated Proton Beam Therapy for Patients with Hepatocellular Carcinoma
https://repo.qst.go.jp/records/45814
https://repo.qst.go.jp/records/458147293abe3-44ab-487f-9c23-4c3fb8f88cd0
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2010-06-16 | |||||
タイトル | ||||||
タイトル | A Prospective Study of Hypofractionated Proton Beam Therapy for Patients with Hepatocellular Carcinoma | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Fukumitsu, Nobuyoshi
× Fukumitsu, Nobuyoshi× Sugahara, Shinji× Nakayama, Hidetsugu× Tsuboi, Koji× et.al× 菅原 信二× 中山 秀次× 坪井 康次 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | PURPOSE: To evaluate the efficacy and safety of hypofractionated proton beam therapy for patients with hepatocellular carcinoma (HCC). METHODS AND MATERIALS: Between September 2001 and August 2004, 51 patients with HCC greater than 2 cm away from the porta hepatis or gastrointestinal tract were treated with proton beam therapy to 66 Gy-equivalents (GyE) in 10 fractions. RESULTS: Overall survival rates were 49.2 and 38.7% at 3 and 5 years after treatment. Local control rates were 94.5 and 87.8% at 3 and 5 years after treatment. Posttreatment serum alpha-fetoprotein values were significantly reduced when compared with pretreatment values (p < 0.0001). Patients experienced only minor acute reactions of Grade 1 or less, and 3 patients experienced late sequelae of Grade 2 or higher. However, there were no treatment-related deaths. CONCLUSIONS: Hypofractionated proton beam therapy is safe and well-tolerated by patients with HCC located greater than 2 cm away from the porta hepatis or gastrointestinal tract and may be effective alternative to other modalities. | |||||
書誌情報 |
International Journal of Radiation Oncology Biology Physics 巻 74, 号 3, p. 831-836, 発行日 2009-07 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0360-3016 |